TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | 307.56%14.02B | ---- | ---- | ---- | 71.33%-6.76B | ---- | ---- |
Profit adjustment | ||||||||||
Investment loss (gain) | ---- | ---- | ---- | -3,282.76%-1.21B | ---- | ---- | ---- | 75.38%-35.85M | ---- | ---- |
Impairment and provisions: | ---- | ---- | ---- | 136.94%1.36B | ---- | ---- | ---- | 83.55%571.95M | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | 136.94%1.36B | ---- | ---- | ---- | 83.55%571.95M | ---- | ---- |
Revaluation surplus: | ---- | ---- | ---- | -502.08%-4.38B | ---- | ---- | ---- | 66.15%-727.03M | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | -502.08%-4.38B | ---- | ---- | ---- | 66.15%-727.03M | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | 12.95%-246.83M | ---- | ---- | ---- | 56.68%-283.55M | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 57.52%-95.31M | ---- | ---- | ---- | 68.08%-224.36M | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | -156.00%-151.53M | ---- | ---- | ---- | -222.68%-59.19M | ---- | ---- |
Depreciation and amortization: | ---- | ---- | ---- | -17.82%8B | ---- | ---- | ---- | 8.99%9.73B | ---- | ---- |
-Depreciation | ---- | ---- | ---- | -17.82%8B | ---- | ---- | ---- | 8.99%9.73B | ---- | ---- |
Financial expense | ---- | ---- | ---- | -10.06%1.42B | ---- | ---- | ---- | 46.50%1.58B | ---- | ---- |
Exchange Loss (gain) | ---- | ---- | ---- | 78.83%-75M | ---- | ---- | ---- | -1,112.87%-354.27M | ---- | ---- |
Special items | ---- | ---- | ---- | -4.11%8.38B | ---- | ---- | ---- | 68.33%8.74B | ---- | ---- |
Operating profit before the change of operating capital | ---- | ---- | ---- | 118.64%27.27B | ---- | ---- | ---- | 213.74%12.47B | ---- | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | 70.52%-141.83M | ---- | ---- | ---- | -1,085.52%-481.07M | ---- | ---- |
Accounts receivable (increase)decrease | ---- | ---- | ---- | -92.97%-727.94M | ---- | ---- | ---- | 49.47%-377.24M | ---- | ---- |
Accounts payable increase (decrease) | ---- | ---- | ---- | 730.69%17.09B | ---- | ---- | ---- | -80.58%2.06B | ---- | ---- |
prepayments (increase)decrease | ---- | ---- | ---- | 724.98%1.48B | ---- | ---- | ---- | 92.50%-237.23M | ---- | ---- |
Special items for working capital changes | ---- | ---- | ---- | -137.94%-4.22B | ---- | ---- | ---- | -507.15%-1.77B | ---- | ---- |
Cash from business operations | ---- | 32.70%25.29B | ---- | 249.48%40.74B | ---- | 1,087.71%19.06B | ---- | 410.34%11.66B | ---- | -39.83%-1.93B |
Other taxs | ---- | -77.29%-254.61M | ---- | 9.87%-222.85M | ---- | -24.72%-143.61M | ---- | 2.93%-247.26M | ---- | 32.14%-115.14M |
Special items of business | 33.71%40.28B | ---- | -25.69%5.98B | ---- | 310.05%30.13B | ---- | 171.38%8.05B | ---- | 231.39%7.35B | ---- |
Net cash from operations | 33.71%40.28B | 32.36%25.04B | -25.69%5.98B | 255.10%40.52B | 310.05%30.13B | 1,025.07%18.92B | 171.38%8.05B | 384.47%11.41B | 231.39%7.35B | -31.95%-2.04B |
Cash flow from investment activities | ||||||||||
Dividend received - investment | ---- | 92.77%35.68M | ---- | -51.13%34.1M | ---- | -62.73%18.51M | ---- | 186.87%69.78M | ---- | 192.63%49.67M |
Loan receivable (increase) decrease | ---- | ---- | ---- | 561.21%909.22M | ---- | 12.68%705.03M | ---- | 374.86%137.51M | ---- | 232.99%625.7M |
Sale of fixed assets | ---- | 129.22%286.85M | ---- | -26.14%301.07M | ---- | 3.57%125.14M | ---- | 283.74%407.6M | ---- | 206.71%120.83M |
Purchase of fixed assets | ---- | -197.11%-5.77B | ---- | -20.03%-6.88B | ---- | 39.74%-1.94B | ---- | 36.39%-5.73B | ---- | 41.88%-3.22B |
Sale of subsidiaries | ---- | -84.96%13.55M | ---- | 21.07%90.05M | ---- | 304.97%90.05M | ---- | 109.34%74.38M | ---- | 94.51%-43.94M |
Recovery of cash from investments | ---- | 125.54%126.76B | ---- | -35.31%117.15B | ---- | -50.75%56.2B | ---- | -50.43%181.1B | ---- | -53.75%114.12B |
Cash on investment | ---- | -41.08%-92.76B | ---- | 28.57%-136.26B | ---- | 44.75%-65.75B | ---- | 53.94%-190.77B | ---- | 53.59%-119.01B |
Other items in the investment business | 164.62%16.64B | ---- | 3,050.67%23.34B | ---- | -60.04%-25.74B | ---- | -106.95%-790.84M | ---- | 59.83%-16.08B | ---88.53M |
Net cash from investment operations | 164.62%16.64B | 370.87%28.57B | 3,050.67%23.34B | -67.63%-24.66B | -60.04%-25.74B | -41.65%-10.55B | -106.95%-790.84M | 74.85%-14.71B | 59.83%-16.08B | 54.67%-7.45B |
Net cash before financing | 1,197.62%56.92B | 540.64%53.61B | 303.85%29.32B | 580.24%15.86B | 150.20%4.39B | 188.16%8.37B | 6,647.64%7.26B | 94.72%-3.3B | 80.85%-8.74B | 47.21%-9.49B |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -72.40%2.31B | ---- | 65.64%42.81B | ---- | 16.67%8.36B | ---- | 1.97%25.84B | ---- | -47.45%7.16B |
Refund | ---- | -137.65%-20.79B | ---- | -30.00%-42.51B | ---- | -129.03%-8.75B | ---- | -241.44%-32.7B | ---- | -36.82%-3.82B |
Issuing shares | ---- | -78.91%24.64M | ---- | 13.59%193.49M | ---- | 28.68%116.88M | ---- | -99.63%170.34M | ---- | -99.79%90.83M |
Interest paid - financing | ---- | 0.50%-219.47M | ---- | 50.26%-578.06M | ---- | 43.97%-220.56M | ---- | -87.41%-1.16B | ---- | -57.61%-393.62M |
Dividends paid - financing | ---- | ---- | ---- | ---2.45M | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---12.45B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | -10,253.01%-47.36B | -0.15%278.29M | -1,997.10%-11.87B | -41.99%278.72M | 132.39%466.5M | -26.74%278.72M | -119.95%-566.04M | -39.29%480.45M | -101.81%-1.44B | -51.93%380.45M |
Net cash from financing operations | -10,253.01%-47.36B | -1,809.81%-32.41B | -1,997.10%-11.87B | 72.16%-2.78B | 132.39%466.5M | -182.47%-1.7B | -119.95%-566.04M | -112.71%-9.99B | -101.81%-1.44B | -97.16%2.06B |
Effect of rate | -411.16%-427.35M | -3.22%167.89M | -120.88%-2.26M | -88.86%104.45M | -85.09%137.34M | -62.04%173.49M | 120.81%10.8M | 238.85%937.5M | 567.67%921.05M | 244.14%457.07M |
Net Cash | 96.90%9.56B | 217.74%21.2B | 160.66%17.45B | 198.38%13.08B | 147.68%4.85B | 189.74%6.67B | 127.32%6.69B | -182.59%-13.29B | -129.90%-10.18B | -113.61%-7.43B |
Begining period cash | 65.39%33.34B | 65.39%33.34B | 65.39%33.34B | -38.00%20.16B | -38.00%20.16B | -38.00%20.16B | -38.00%20.16B | 90.21%32.51B | 90.21%32.51B | 90.21%32.51B |
Cash at the end | 68.87%42.47B | 102.59%54.7B | 89.05%50.78B | 65.39%33.34B | 8.14%25.15B | 5.74%27B | -24.13%26.86B | -38.00%20.16B | -54.34%23.26B | -64.23%25.54B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.